Vera Therapeutics, Inc. — All Filings
433 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-25-297161 | Nov 25, 2025 | Nov 21, 2025 |
| 144 | — | 0001193125-25-294092 | Nov 24, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000840 | Nov 14, 2025 | — |
| 4 | 4 | 0001193125-25-280792 | Nov 13, 2025 | Nov 11, 2025 |
| 8-K | 8-K | 0001193125-25-268331 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-266881 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-265799 | Nov 5, 2025 | — |
| SCHEDULE 13G | — | 0001085146-25-005108 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-102399 | Aug 5, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-103022 | Aug 5, 2025 | Jun 30, 2025 |
| 424B5 | 424B5 | 0001193125-25-173588 | Aug 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-173591 | Aug 5, 2025 | — |
| 4 | 4 | 0000950170-25-090110 | Jun 25, 2025 | Jun 23, 2025 |
| SCHEDULE 13G | — | 0001193805-25-000870 | Jun 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-133730 | Jun 3, 2025 | Jun 2, 2025 |
| 8-K | 8-K | 0001193125-25-132736 | Jun 2, 2025 | — |
| 8-K | 8-K | 0000950170-25-074446 | May 19, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013421 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013417 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013423 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013408 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013412 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013415 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013420 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0001415889-25-013419 | May 16, 2025 | May 14, 2025 |
| 10-Q | 10-Q | 0000950170-25-064733 | May 7, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-063975 | May 6, 2025 | — |
| ARS | ARS | 0001140361-25-012039 | Apr 3, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001140361-25-012034 | Apr 3, 2025 | May 14, 2025 |
| DEFA14A | DEFA14A | 0001140361-25-012036 | Apr 3, 2025 | — |
| 10-K | 10-K | 0000950170-25-029969 | Feb 28, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001193125-25-042606 | Feb 28, 2025 | — |
| 4 | — | 0001415889-25-005841 | Feb 27, 2025 | Feb 21, 2025 |
| 144 | — | 0001950047-25-001279 | Feb 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-027337 | Feb 26, 2025 | — |
| 4 | — | 0001415889-25-004849 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004846 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004851 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004844 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004845 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004847 | Feb 20, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-000985 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-005010 | Jan 13, 2025 | — |
| 4 | — | 0001415889-25-001242 | Jan 10, 2025 | Jan 8, 2025 |
| 144 | — | 0001950047-25-000187 | Jan 8, 2025 | — |
| 4 | — | 0001415889-24-029964 | Dec 20, 2024 | Dec 18, 2024 |
| 144 | — | 0001950047-24-009959 | Dec 18, 2024 | — |
| 4 | — | 0001415889-24-029275 | Dec 13, 2024 | Dec 11, 2024 |
| 144 | — | 0001950047-24-009703 | Dec 11, 2024 | — |
| 4 | — | 0001415889-24-027840 | Nov 27, 2024 | Nov 25, 2024 |